Cancer Research Institute of the Slovak Academy of Sciences

Recent papers from Cancer Research Institute of the Slovak Academy of Sciences

1. Exploring the potential of vamotinib in Ph+ leukemias: is it indeed a 3rd generation tyrosine kinase-inhibitor?Journal of Hematology & Oncology · 2026
2. Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1Journal of Human Immunity · 2026
3. Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinomaFrontiers in Immunology · 2026
4. Evaluation of the radiomodifying effects of Ginkgo biloba in radioresistant triple negative breast cancer cellsFrontiers in Public Health · 2026
5. Leptospermum scoparium Essential Oil: Antibacterial Properties, Cyto/Genotoxic Effects, Antioxidant Activity, and Wound-Healing Potential In VitroMolecules · 2026
6. Spatialgater: an R Shiny webtool for in situ gating of cells in spatial omics experimentsBMC Bioinformatics · 2026
7. A low-cost indigenous self-retaining perineal retractor: Design and early clinical evaluationTropical Doctor · 2026
8. Perioperative chemotherapy with FLOT in the setting of curative treatment of gastric adenocarcinoma: impact in the survival and pathologic downstaging - systematic reviewWorld Journal of Surgical Oncology · 2026
9. Aligning patient navigation activities with the early cancer care agenda in LMICs: a framework for implementation across the cancer continuumBMC Cancer · 2026
10. 2 Relationships Between Plasma KIM-1 Levels, Peripheral Immune Profiles and Disease-Free Survival Outcomes in the TransRAMPART StudyThe Oncologist · 2026
11. Validation of the advanced‐stage Hodgkin lymphoma international prognostic index (A‐HIPI) in the GHSG HD21 trialHemaSphere · 2026
12. EXPRESSION PATTERNS AND CLINICAL SIGNIFICANCE OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2/neu IN GALLBLADDER CANCERExperimental Oncology · 2026
13. A Coordinated Mitochondrial Genome Expression Program Marks a Differentiated Neural-Lineage and Synaptic Transcriptional State in Lower-Grade GliomaInternational Journal of Molecular Sciences · 2026
14. How I treat autoimmune neutropenia in adultsBlood · 2026
15. CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancerNeoplasma · 2026
16. Central Nervous System Metastases in Metastatic Breast Cancer: Incidence, Subtype-Specific Patterns, and Outcomes from the Austrian AGMT_MBC RegistryThe Breast · 2026
17. A splice odyssey: periostin’s journey through the sea of crabsNeoplasma · 2026
18. Low-affinity CD8+ T cells drive cerebral malaria and redefine the afifnity-effector paradigm 2262761The Journal of Immunology · 2026
19. Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review studyFrontiers in Immunology · 2026
20. NGFR expression predicts tumor recurrence in radiotherapy/chemoradiotherapy-treated HPV-negative pharyngeal squamous cell carcinomaOral Oncology · 2026